Insider Transactions Reported by 17 Insiders of ALX ONCOLOGY HOLDINGS INC

Symbol
ALXO on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

ALX ONCOLOGY HOLDINGS INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
LSV Associates, LLC 10%+ Owner $61,575,751 13 Dec 2021
Sophia Randolph Chief Medical Officer $840,334 14 Aug 2024
Jaume Pons President & Cso $666,412 -$1,525 -0.23% 19 Feb 2025
Jason Lettmann CHIEF EXECUTIVE OFFICER, Director $329,683 +$95,344 +41% 14 Oct 2025
PETER S. GARCIA Chief Financial Officer $313,511 14 Aug 2024
Barbara Klencke Director $216,000 17 Sep 2025
Chris H. Takimoto Director $72,720 21 Jan 2025
J. Scott Garland Director $72,720 21 Jan 2025
Harish Shantharam Chief Financial Officer $58,402 +$58,403 14 Oct 2025
Shelly Pinto Svp, Finance And Cao $57,122 -$2,588 -4.3% 14 Oct 2025
Rekha Hemrajani Director $51,044 21 Jan 2025
Jack Nielsen Director, 10%+ Owner 20 Jun 2023
Alan B. Sandler Chief Medical Officer 11 Apr 2025
Graham G. Walmsley Director 11 Jun 2021
Daniel J. Curran Director 12 Aug 2025
Itziar Canamasas Director 20 Jun 2023
COREY S. GOODMAN Director, 10%+ Owner 21 Jan 2025

Recent Insider Transactions by Companies or Individuals for ALX ONCOLOGY HOLDINGS INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.